Danish researchers published a study suggesting that COVID-19 increases the risk of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
https://www.pharmalive.com/wp-content/uploads/2022/06/BioSpacebrain6-28-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-06-28 11:18:292022-06-28 11:18:29New study: COVID-19 may cause or accelerate neurological diseases